Featured Research

from universities, journals, and other organizations

A new way to treat uterine fibroids

Date:
September 30, 2013
Source:
Meridian Health
Summary:
A new minimally invasive treatment for a common women’s health problem is now offered in New Jersey.

Jersey Shore University Medical Center announces today that Mark Martens, M.D., chief of Obstetrics and Gynecology, performed the first Acessa procedure in New Jersey. The procedure is used for the treatment of uterine fibroids. Additionally, Jersey Shore’s Jocelyn A. Carlo, M.D., Obstetrics/Gynecology, is performing the procedure.

Uterine fibroids are benign growths on the uterus that usually occur during childbearing years. While most fibroids are asymptomatic, some may grow and cause heavy menstruation, painful sexual intercourse, and urinary tract problems. In rare cases, fibroids may complicate pregnancy. As many as 3 out of 4 women have uterine fibroids by the time they reach 50.

The Acessa procedure is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy the fibroids. After treatment, the fibroids are re-absorbed by the surrounding tissue. Acessa allows the doctor to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. More than 300 women have been successfully treated with Acessa.

“We are delighted to introduce patients to the Acessa procedure,” says Dr. Martens. “It represents a major breakthrough in the treatment of uterine fibroids—a common and potentially uncomfortable health issue.”


Story Source:

The above story is based on materials provided by Meridian Health. Note: Materials may be edited for content and length.


Cite This Page:

Meridian Health. "A new way to treat uterine fibroids." ScienceDaily. ScienceDaily, 30 September 2013. <www.sciencedaily.com/releases/2013/09/130930161816.htm>.
Meridian Health. (2013, September 30). A new way to treat uterine fibroids. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130930161816.htm
Meridian Health. "A new way to treat uterine fibroids." ScienceDaily. www.sciencedaily.com/releases/2013/09/130930161816.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins